ARGENX SE is 31.9x more valuable than aTYR PHARMA INC by market capitalization ($53.35 B vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIFE | ARGX |
|---|---|---|
| Market cap | $1.67 B | $53.35 B |
| US-listed rank | #2240 | #306 |
| Revenue (latest FY) | $190.00K | - |
| Net income (latest FY) | -$74.12M | - |
| Net margin | -39009.5% | - |
| SEC filings | 720 | 272 |
ARGENX SE is 31.9x more valuable than aTYR PHARMA INC by market capitalization ($53.35 B vs $1.67 B).
Full pages: aTYR PHARMA INC and ARGENX SE, or browse the full rankings.